Who Paid My Doc
A22-301
Research payments
$3,978,800
Through program year 2025, $3,978,800 in research payments was reported against A22-301, across 249 payments, paid by PharmaEssentia USA Corporation.
- Paid by
- PharmaEssentia USA Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $3,617,364 | 235 |
| 2023 | Research | $361,436 | 14 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lindsay Rein Durham, NC Named on 39 payments
- Anthony Hunter Tampa, FL Named on 21 payments
- Casey O'Connell Los Angeles, CA Named on 19 payments
- Brandi Reeves Chapel Hill, NC Named on 18 payments
- Pankit Vachhani Birmingham, AL Named on 17 payments
- Swati Goel Bronx, NY Named on 14 payments
- Jennifer Lucas Greenbrae, CA Named on 11 payments
- Tsewang Tashi Salt Lake City, UT Named on 11 payments
- Anna Halpern Seattle, WA Named on 10 payments
- Stephen Oh Saint Louis, MO Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.